J. Martin

Severity of vertebral fracture reflects deterioration of bone microarchitecture

Harry K. Genant, Peiqi Chen, Robert Marcus, 2006, Osteoporosis International.

DIFFERENTIAL EF ECTS OF TERIPARATIDE ON BONE MINERAL DENSITY AFTER TREATMENT WITH RALOXIFENE OR ALENDRONATE

B. Ettinger, I. Pávó, G. Crans, 2004 .

Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss

J. Nadol, S. Helfgott, S. Helfgott, 1991, The Lancet.

Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk.

S. Cummings, O. Tørring, S. Boonen, 2011, The Journal of clinical endocrinology and metabolism.

Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy

J. Kaufman, G. Dalsky, B. Mitlak, 2005, Osteoporosis International.

Effect of raloxifene after recombinant teriparatide [hPTH(1–34)] treatment in postmenopausal women with osteoporosis

D. Felsenberg, G. Dalsky, J. S. San Martin, 2007, Osteoporosis International.

RNAi inhibition of angiopoietin-like protein 3 (ANGPTL3) with ARO-ANG3 mimics the lipid and lipoprotein profile of familial combined hypolipidemia

S. Melquist, J. Knowles, P. Clifton, 2020 .